Stuhini Exploration Ltd. (TSXV:STU)

Sage Therapeutics Balance Sheet

Financials in millions CAD. Fiscal year is March - February.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 28, 2025	Feb 29, 2024	Feb 28, 2023	Feb 28, 2022	Feb 28, 2021
Cash & Equivalents	0.44	0.89	0.96	0.95	0.87
Short-Term Investments	0.1	0.6	0.2	-	-
Trading Asset Securities	-	-	-	0.2	0.29
Cash & Short-Term Investments	0.54	1.49	1.16	1.16	1.16
Cash Growth	-63.80%	28.55%	-0.17%	-0.35%	21.35%
Other Receivables	0.01	0.09	0.12	0.09	0.07
Receivables	0.01	0.09	0.12	0.09	0.07
Prepaid Expenses	0.12	0.12	0.13	0.15	0.16
Total Current Assets	0.67	1.69	1.41	1.4	1.39
Property, Plant & Equipment	9.41	9.82	8.19	5.02	1.9
Other Long-Term Assets	0.18	0.19	0.09	0.05	0.03
Total Assets	10.26	11.7	9.69	6.47	3.32
Accounts Payable	0	0.01	0.07	0.11	0.01
Accrued Expenses	0.12	0.1	0.1	0.12	0.03
Short-Term Debt	-	-	-	0.12	0.05
Current Unearned Revenue	-	-	0.01	-	-
Total Current Liabilities	0.12	0.1	0.18	0.36	0.08
Long-Term Deferred Tax Liabilities	-	0.18	0.34	-	-
Total Liabilities	0.12	0.28	0.52	0.36	0.08
Common Stock	13.84	13.82	10.88	7.09	3.96
Retained Earnings	-4.84	-3.44	-2.4	-1.56	-0.95
Comprehensive Income & Other	1.14	1.04	0.68	0.58	0.22
Shareholders' Equity	10.14	11.42	9.16	6.11	3.23
Total Liabilities & Equity	10.26	11.7	9.69	6.47	3.32
Total Debt	-	-	-	0.12	0.05
Net Cash (Debt)	0.54	1.49	1.16	1.04	1.12
Net Cash Growth	-63.80%	28.55%	11.38%	-7.07%	16.63%
Net Cash Per Share	0.01	0.03	0.04	0.05	0.07
Filing Date Shares Outstanding	46.48	46.48	46.36	26.15	20.11
Total Common Shares Outstanding	46.48	46.36	38.49	25.97	19.77
Working Capital	0.55	1.59	1.23	1.04	1.31
Book Value Per Share	0.22	0.25	0.24	0.24	0.16
Tangible Book Value	10.14	11.42	9.16	6.11	3.23
Tangible Book Value Per Share	0.22	0.25	0.24	0.24	0.16
Machinery	0	0	0	0	0

Source: S&P Global Market Intelligence. Standard template. Financial Sources.